Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal
year beginning in) ![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2019 | (b) 2020 | (c) 2021 | (d) 2022 | (e) 2023 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2023 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2023 |
(iii) Distributable Amount for 2023 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2023 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2023 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2023: | ||||
| a From 2018....... | ||||
| b From 2019....... | ||||
| c From 2020....... | ||||
| d From 2021....... | ||||
| e From 2022....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2023 distributable amount | ||||
|
i
Carryover from 2018 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2023 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2023 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2023, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2023. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2024. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2019..... | ||||
| b Excess from 2020..... | ||||
| c Excess from 2021..... | ||||
| d Excess from 2022..... | ||||
| e Excess from 2023..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | 23017659 |
| Software Version: | 23.1.0.0 |
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4d | Program Service Expenses 2,788,329, Grants and allocations 0, Revenue 2,000,275 See Schedule O |
| Form 990, Part VI, Section B, Line 11B | The Form 990 is presented to the Board Members at a regularly scheduled meeting or it is distributed electronically for review prior to submission. |
| Form 990, Part VI, Section B, Line 12C | Annually, all officers, directors, trustees, and key employees are provided a copy of the Conflict of Interest Policy and required to sign a statement either identifying potential conflicts or confirming that no such conflicts exist. |
| Form 990, Part VI, Section B, Line 15 | The President of CARES engages an outside entity every third year to conduct a market analysis and salary comparability study to determine if the salary for the CEO is in an acceptable range. The report from the outside entity is shared with the Board of Directors at a regularly scheduled meeting. The discussion is recorded in the minutes. |
| Form 990, Part VI, Section C, Line 19 | CARESs governing documents, Conflict of Interest Policy, and financial statements are made available to the public upon request. |
| Form 990, Part III, Line Line 4a | Caring Connections A program to alleviate social isolation and loneliness in individuals living with spinal cord injury conducted by Dr. Sherri Lavela at Edward Hines Jr. VA Hospital. The findings of this study have revealed how persons with SCI/D conceptualize loneliness and social isolation, and both constructs encompassed feeling alone along with other emotional states such as darkness and sadness lack of meaningful interactions and brought to light patient views on driving factors. Findings can be used to develop social health interventions and guide patient-provider discussions that address meaningful aspects of loneliness and social isolation as perceived by individuals and suggest that efforts are needed to better identify and respond to social isolation and lonliness in community and healthcare settings. These findings will help us build and refine the intervention design and content for the current grant. |
| Form 990, Part III, Line Line 4b | COVID-19 vaccine safety monitoring surveillance Rapid Cycle Analysis Queries Risk Assessment/Evaluation funded by the CDC. Under this study, adverse events of special interest AESIswill be identified through ICD-10 diagnosis codes in CDW databases for Veterans who received COVID-19 vaccines. Prespecified potential AESIs will be identified from inpatient and emergency visits for most outcomes and a small number of pre-specified outcomes will also be identified from outpatient visits. The potential associations between vaccine administration and pre-specified adverse events will be evaluated in near real-time employing a technique called rapid cycle analysis RCA. Specifically, a Poisson-based maximized sequential probability tes MaxSPRT will be employed. Other approaches may also be adopted in order to monitor the safety of COVID-19 vaccines in near real-time e.g. Bayesian, vaccinated vs unvaccinated matched on date of vaccination, etc. SafeRx Post-Market Medical Product Surveillance funded by the FDA. The purpose of this study was to enhance drug safetly knowledge and expand and develop better tools and techniques for assessing drug safety through information sharing and the exploitantion of VA and FDA synergies in a variety of areas of scientific expertise. The goals of collaboration were to expore ways to - Further enhave informatoin sharing efforts through more efficient and robust inter-agency activities - Promote efficient utilization of tools and expertise for product risk identification, validation, and analysis - Build infrastructure and processes that meet the common needs for evaluating drug safety. These studies were conducted by Dr. Cunningham Francesca at Edward Hines, Jr. VA Hospital. |
| Form 990, Part III, Line Line 4c | Enhancing regeneration and improving function after SCI study conducted at Edward Hines Jr. VA Hospital in Dr. Kartjes laboratory. The goal of the project is to determine if anti-Nogo A antibodies produced by NovaGo result in regeneration and functional recovery post-spinal cord injury in adult rats |
| Form 990, Part III, Line Line 4d | The Chicago Association for Research and Education in Science CARES has been serving veterans since 1984. The primary tax-exempt purpose of CARES is biomedical, clinical and health services research as well as health related educational activities in collaboration with the Edward Hines Jr. VA Hospital and the Captain James A. Lovell Federal Health Care Center, William S. Middleton VA Hospital and Jesse Brown VA Medical Center. This research benefits United States Veterans being treated at all four VA sites and the general public by advancing knowledge in the diagnosis and treatment of disease and disability. Education activities include the dissemination of research results through publication in quality medical journals and presentation at professional meetings all of which are intended to translate research results to clinical practice. Other education is geared to helping patients and their families understand and manage their medical conditions. During the past year, CARES supported more than 100 individual researchers who cumulatively are conducting research projects in the following diabetic foot ulcers, antibiotic-resistant infections, hypertensive renal injury, osteoporosis, retinopathy, bladder function, neurofibromatosis, chronic obstructive pulmonary disease, inflammatory bowel disease, diabetes, rehabilitation research and development, pressure ulcers, hypertension, infectious diseases, cancer, cardiovascular disease, mental health, stroke, health services and outcomes research, kidney disease, veteran engagement, mechanical ventilation, traumatic brain injury, spinal cord injury, musculoskeletal biomechanics, and more. |
| Software ID: | 23017659 |
| Software Version: | 23.1.0.0 |